# BRIGHAM AND WOMEN'S HOSPITAL: Nicotinamide Adenine Dinucleotide Augmentation to Prevent or Reverse the Progression of Alzheimer's Disease in People with Down Syndrome

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | BRIGHAM AND WOMEN'S HOSPITAL |
| Location | BOSTON, MA |
| Project | Nicotinamide Adenine Dinucleotide Augmentation to Prevent or Reverse the Progression of Alzheimer's Disease in People with Down Syndrome |
| Project number | 5R01AG088141-02 |
| Mechanism | R01 |
| Institute | National Institute on Aging |
| Award | $801,611 |
| Awarded | 2026-09-09 |
| Project period | 2025-09-15 to 2028-08-31 |
| UEI | QN6MS4VN7BD1 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11411154). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.